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Objectives: To determine the genetic and phenotypic composition of HIV-1 found in the choroid
plexus (CPx) and its relationship to virus in the brain and peripheral lymphoid tissue.
Design: Phenotypic and molecular comparisons of HIV-1 found in autopsy brain, CPx, and
spleen tissues.
Methods: HIV-1 was co-cultured from matched postmortem brain (basal ganglia), CPx, and
spleen tissues of AIDS patients with and without HIV-associated encephalitis and dementia.
Viral phenotypes were determined by infection of monocyte-derived macrophages, MT-2 or
co-receptor-specific cell lines. Viral env and pol sequences were determined from genomic DNA
isolated directly from tissues or co-cultures, and phylogenetic comparisons were performed.
Results: CCR5-utilization was the most prevalent viral tropism found in all tissues, although
spleen isolates also displayed CXCR4 usage. Viruses isolated from CPx consisted of both
peripheral and brain-like virus, but were more related phenotypically and genetically to those
found in the brain. Mutations found in the pol gene that could confer drug resistance to brain
and CPx isolates were similar to those found in the periphery.
Conclusion: The CPx contained replication-competent virus that was most similar, although
distinct, from that found in the brain. It also contained some viruses with high similarity to
those of peripheral origin. Compartmentalization of viral env and pol sequences indicated that
differential selective pressures exist in each tissue examined. These studies suggest that the CPx
may provide an environment that promotes the evolution of drug-resistant strains with central
nervous system tropism, although it is unlikely to be a reservoir for archival HIV-1 variants.
Keywords: brain, choroid plexus, compartmentalization, drug resistance, env, HIV-1, pol

(HAD) are not understood. HIV-1 enters the central nervous system (CNS) early during primary infection and
can be isolated from cerebrospinal fluid (CSF) at this
time [1]; however, viral replication in the brain is rare before the onset of immunosuppression and AIDS. Once
infection of the brain has been established, the virus appears to undergo independent micro-evolution or com-

Introduction
Morbidity caused by neurological complications of HIV-1
infection has become increasingly common since the implementation of highly active antiretroviral therapy
(HAART), as a result of the prolonged life expectancy of
infected individuals. The events leading to HIV-1 brain
infection and progression to HIV-1-associated dementia
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partmentalization, an effect commonly observed in other
tissues [2–5]. Compartmentalization probably has clinical implications on therapy by reducing the effectiveness
and durability of drug treatment and vaccination strategies by the sequestration of drug-resistant mutants and
the evolution of neurotoxic quasispecies.
The choroid plexus (CPx), the main tissue involved in the
secretion and regulation of CSF, may play a key role in
the neuropathogenesis of HIVencephalitis (HIVE). The
CPx consists of two fluid–cellular interfaces, one with
capillary blood and one with CSF. The CPx endothelial
cells express adhesion molecules that initiate lymphocyte
migration in response to inflammation, but unlike the
blood–brain barrier are not joined by tight junctions [6–
8]. The epithelial layer of the CPx forms the blood–CSF
barrier of the brain; these cells are joined by tight junctions and regulate the bidirectional entry of macromolecules, ions, cells, and perhaps virus, between the blood,
CSF, and brain parenchyma [6, 9]. The close proximity
of readily permissive monocytes and T cells in the CPx
stroma implies its involvement in the transmission of virus between the CNS and peripheral compartments [10].
Previous studies have suggested that the CPx is a site
for viral dissemination into the CNS as the viral genotypes isolated from CPx tissues demonstrated similarity with those from the peripheral and CNS compartments [11, 12]. However, such studies were limited to
formalin-fixed paraffin-embedded tissues, and we were
thus unable to study the properties of CPx-derived virus. Accordingly, in this study, we isolated viruses from
autopsy tissue samples of brain, CPx, and spleen from
three AIDS patients to characterize the viral genotypes
and phenotypes found in these three tissue compartments. Our results confirm that the CPx contains a composite of viruses with properties similar to those found
in both brain and spleen tissues.
Methods
Case selection and tissue preparation
All tissues were obtained with Internal Review Board
approval from the University of Miami according to National Institutes of Health (NIH) guidelines. At autopsy,
fresh brain was bisected in the mid-saggital plane and
pieces of basal ganglia, frontal lobe and CPx from the
trigone of the lateral ventricle were washed several times
in phosphate-buffered saline to remove blood contamination, and were rapidly frozen at 708C. Spleen tissues
were treated similarly. Additional tissue samples from
HIV-1-infected patients and controls were donated by
the National NeuroAIDS Tissue Consortium in Galveston, Texas, USA (MH59656) and the University of Miami
Brain and Tissue Bank (N01 HD83284). Determination
of HAD was based on records provided by the National
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NeuroAIDS Tissue Consortium and American Academy
of Neurology criteria using clinical records [13]. Neuropathological examination of brain tissue sections acquired at the University of Miami was performed using
hematoxylin and eosin-stained sections.
Virus Isolation
Tissue samples were thawed, washed twice with phosphate-buffered saline, and ground through a 100 mm
cell strainer (BD Bioscience, USA) with the addition of
RPMI containing 10% fetal bovine serum (Nova-tech,
NE, USA) to obtain a tissue homogenate. Phytohemagglutinin-stimulated peripheral blood mononuclear cell
(PBMC) cultures containing 10 U/ml human IL-2 were
inoculated with the cell suspension (Roche, Indianapolis, IN, USA). PBMC used in the study were obtained
from a local blood bank and were a pool of PBMC from
two to four anonymous donors. Cells were cultured for
5 days before replacing the media and supplementing
with fresh uninfected phytohemagglutinin-stimulated
PBMC. HIV-1 p24 antigen capture assays (Coulter, USA)
of culture supernatants at 5, 10, and 15 days post-infection confirmed the production of virus from tissue homogenate co-cultures. Cell-free culture supernatants
collected 14–21 days post-infection were used to infect
fresh PBMC. Genomic DNA was extracted from approximately 107 first passage PBMC, or from tissue (50 mg) according to the manufacturer’s protocol (Gentra, USA).
Virus phenotypic analyses
Co-receptor usage was determined by infecting each of
the GHOST(3) chemokine receptor-expressing cell lines
obtained from the NIH AIDS Reagent and Reference Reagent Program (i.e. CCR1, CCR2, CCR3, CCR4, CCR5,
CCR8, CXCR4, CXCR6, CX3CR1, BOB, CCR3/CCR5/
CXCR4). Approximately 100 TCID50 of primary virus isolates (per 7.5 mm2 well) were used to infect each
GHOST(3) cell line for 36 h before analysis by fluorescence microscopy. The co-receptor assay was performed
three times independently, each in triplicate, and was
scored qualitatively in comparison with the background
observed for the chemokine receptor-negative GHOST(3)
parental line.
Virus isolates were evaluated for syncytium formation
by infection of MT-2 and C8166 T-cell lines. An assessment of productive infection of macrophages was performed with infection of adherent monocytes derived
from PBMC. The culture supernatant was monitored for
HIV-1 p24 production by antigen capture immunoassay
(Coulter) for 15 days post-infection.
Polymerase chain reaction and sequencing
For all genetic analyses, DNA isolated from first passage
co-cultures of tissues from the three virus-positive indi-
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viduals plus DNA isolated directly from the three tissues of two virus-negative cases were used. For env
gene analyses, proviral DNA was amplified using the
ED3 and ED14 primers and ED5 and ED12 primers, in
a nested reaction as previously described [14]. Amplification of pol sequences for resistance mutation analysis
was performed using the JA203-206 set of nested primers
[15]. When possible, first-round polymerase chain reaction (PCR) products were cloned using the pCR4-TOPO
TA cloning vector (Invitrogen, USA). Cloned HIV-1 env
sequences were screened by heteroduplex mobility assay (previously described by Delwart et al. [16]), and
only those clones that were genetically distinct were sequenced using the ED31 primer to obtain the V3 region
data. DNA sequences of cloned pol and env fragments
(corresponding to 2135–3338 and 7017–7322 in HXB2,
respectively) were determined and analysis was performed using the Vector NTI suite of programs (Version
9.0; InforMax, UK) and CLUSTALW. Potential N-linked
glycosylation sites were identified using the N-glycosite
program available on the HIV Sequence Database website (http://www.hiv.lanl.gov/).
Phylogenetic Analyses
Phylogenetic and molecular evolutionary analyses were
conducted using MEGA version 2.1 [17]. Estimations of
genetic distance were made using MEGA with 1000 bootstrap replicates. The statistical significance of differences
in net charge distribution between tissues of the same
patient was evaluated using an unpaired t-test. Drug resistance and other mutations were identified using the
Stanford HIV Drug Resistance Database (http://hivdb.
stanford.edu/). Co-receptor usage prediction for sequences was performed using the web PSSM software
(http://ubik.microbiol.washington.edu/computing/
pssm/).
Sequence Data
The sequence data generated in this study were deposited into GenBank under the accession numbers AY6
53552–AY653632 and AY874175–AY874233 for pol, and
AY653633–AY653728 and AY874234–AY874280 for env
sequences.
Results
Virus isolation and phenotypic characterization
We obtained a total of 80 HIV-1-infected tissue samples
from 31 AIDS patients, seven tissues from three HIV-1infected asymptomatic patients, and seven tissues from six
uninfected control patients (Table 1). The HIV-1-positive
groups had a younger average age, and higher, more
variable postmortem interval than the HIV-1-negative
controls. The successful isolation of HIV-1 from these tissues correlated with the disease status and with the tis-

Figure 1. Phylogenetic analysis and characterization of HIV-1
env sequences. (a) Neighbor-joining phylogenetic tree (1000
bootstrapped replicates) of deduced HIV-1 env amino acid sequences (265–366 HIVHXB2 Env) isolated from brain, choroid
plexus (CPx), and spleen tissues of cases A–E. Circles indicate
sequences from patient A, diamonds indicate sequences from
patient B, squares indicate sequences from patient C, triangles
indicate sequences from patient D, and inverted triangles indicate sequences from patient E. Open symbols represent brain
sequences, grey symbols represent CPx sequences, and black
symbols represent spleen sequences. Numbers on each branch
indicate bootstrap values. NL4-3 (M19921) was included as
an outgroup. (b–f) Alignments of deduced env amino acid sequence of molecular clones from brain (Br), choroid plexus
(CPx), and spleen (Sp) tissues of patients A–E (panels b–f, respectively) representing residues 265–366 of HIVHXB2 Env.
*Only one sequence was obtained as a result of a lack of tissue
sample. # Number of clones sequenced with the sequence indicated; periods (.) indicate gaps in the alignment, dashes (—) indicate identity with the consensus sequence, shaded sequences
indicate potential N-linked glycosylation sites.
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sue source, but did not correlate with HAART treatment,
brain pathology, postmortem interval or PCR amplification for env sequences. Despite PCR detection of HIV-1
in a large number of samples, we successfully cultured
HIV-1 in only 19.4% of the AIDS patients from at least
one tissue and none from the asymptomatic group. Virus
was most frequently isolated from basal ganglia (27%),
with a similar success from both CPx and spleen samples (18 and 12%), and was unsuccessful from frontal or
temporal cortical tissues (Table 1). Of the six cases that
yielded viable virus, the neuropathological changes included: two with HIVE, (a) two with meningitis, and
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one each with lymphoma or white matter gliosis. The
postmortem interval of these six patients averaged 10.8 h
and ranged from 8 to 16 h.
Among the six virus-positive cases, three had viruses isolated from all three tissues (brain, spleen, and CPx), and
these isolates were further characterized (denoted A–C;
Table 2). All brain and CPx virus isolates were exclusively
macrophage tropic in vitro and preferentially utilized the
CCR5 for viral entry. All spleen isolates were able to replicate in primary macrophages and T-cell lines, and displayed preferential usage of the CCR5 and CXCR4

Figure 2. Observed mutations and phylogenetic analysis of HIV-1 pol sequences. (a and b) The presence of relevant resistance-associated mutations at significant sites in pol for brain, choroid plexus (CPx), and spleen tissues of patients A–E compared with consensus drug-naive subtype B sequence (WT). Only those mutations that occurred in more than one clone are reported. (a) Mutations
found in protease region; (b) mutations in reverse transcriptase region. (c) Neighbor-joining phylogenetic tree (1,000 bootstrapped
replicates) of deduced HIV-1 pol amino acid sequences (17–418 HIVHXB2 Pol) isolated from brain, CPx, and spleen tissues of cases
A–E. Circles indicate sequences from patient A, diamonds indicate sequences from patient B, squares indicate sequences from patient C, triangles indicate sequences from patient D, and inverted triangles indicate sequences from patient E. Open symbols represent brain sequences, grey symbols represent CPx sequences, and black symbols represent spleen sequences. Numbers on each
branch indicate bootstrap values. NL4-3 (M19921) was included as an outgroup.
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specific variation that was discrete, but phylogenetically
related (Figure 1a). Three out of five patients’ brain and
CPx sequences were more genetically similar to one another than to spleen tissue when comparisons of the average intratissue genetic distance were used (data not
shown). Patient E showed no compartmentalization, but
did show two distinct lineages that contained sequences
from all three tissues. Generally, for HIVE-positive individuals (A, B, D, and E), the intratissue genetic distance
of env was highest in the spleen, the number of potential N-linked glycosylation sites were reduced in brain
env sequences, and the V3 loop net charge was less positive when compared with spleen env sequences (Figures
1b–d). Coreceptor usage prediction programmes found
that those CPx sequences that showed great similarity to
spleen sequences were also CXCR4-utilizing strains.

Figure 2. (continued)

co-receptors. In cross-infection experiments of CXCR4
and CCR5 co-receptor lines, we found that spleen virus
was indeed a mixture of viruses rather than dual-tropic
for both co-receptors. All viral isolates also exhibited
multiple tissue-specific minor chemokine co-receptor usage in GHOST(3) cell lines (Table 2). The co-receptors utilized by brain viral isolates included CCR2, CCR3, CCR4
and CXCR6; all CPx isolates utilized the CCR3, CCR4,
and CXCR4 co-receptors to a lesser extent than CCR5.
Viral isolates from the spleen commonly utilized CCR3,
CCR4, CCR6, CCR8 and CX3CR1.
Compartmentalization of HIV-1 env
The V3 region of env from five patients with amplifiable
env sequences from three tissue compartments (Table 2)
was chosen for genetic analyses because it contains sequences that are most indicative of viral tropism, especially co-receptor usage. All sequences obtained in this
study were patient-specific, as sequences from each individual patient clustered together and contamination
from laboratory strains was ruled out phylogenetically
(Figure 1a). Each patient had env sequences that divided
into at least two subgroups, indicating a level of tissue-

Compartmentalization of viral pol
Drug resistance mutations identified in the pol gene of viral isolates were determined by comparison with existing resistance sequences found in the Stanford drug resistance database (Figures 2a and b). Although potential
drug resistance mutations were detected in tissues from
all patients studied, the purpose of analysing these populations was also to examine the compartmentalization
of viral pol sequences in comparison with env. As the pol
gene is under strong selective pressure by antiretroviral
drugs during treatment, whereas env is under immunological selective pressure, this comparison is warranted.
Phylogenetic comparisons of amino acid sequences obtained from the pol of HIV-1 isolates showed a similar
grouping pattern as for env (Figure 2c), but with some
notable differences. Generally, pol sequences from the
brain grouped together for each subject, but in some instances also showed significant similarity to spleen sequences. All five patients investigated had evidence of
two pol genotype lineages that could be phylogenetically
distinguished from each other, and in four out of five
cases (A–D) this division was indicative of tissue compartmentalization. Furthermore, CPx virus commonly
formed a unique group, but was more often related to
the brain sequences than to those of peripheral origin.
Interestingly, CPx sequences often showed extensively
more G → A hypermutation that resulted in the introduction of stop codons than other tissues, but these sequences were not used in subsequent analyses. Although
most of the cases in this study were treated with HAART
(case B history was unknown), specific details of their
drug treatment histories were not available. However,
based on sequence analysis of pol, all cases revealed multiple amino acid mutations that possibly conferred resistance to antiretroviral drugs (Figures 2a and b). In addition, subject C showed significant sequence differences
in the pol gene from spleen virus compared with those
from the brain; a relationship that is distinct from the env
sequences. Other areas of hypermutation in the reverse
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transcriptase (RT) gene showed tissue-specific distribution (data not shown) but were not predictive of drug resistance.
Discussion
The CPx is a highly vascularized CNS tissue that provides a barrier between the circulatory system and the
CSF, and is responsible for the production and maintenance of CSF. Because both blood and CSF contact the
surfaces of the CPx, it is critical to understand the mechanisms whereby HIV-1 interacts with or infects the CPx.
A recent report using pseudoviruses in mice [18] suggested that HIV-1 accesses the CSF via a rapid transport
process, possibly transcytosis through the CPx. However, during chronic disease, CSF viral load correlates
with neurological disease progression [19–21], but it is
unclear whether the origin of virus found in the CSF is
from resident immune cells in the CSF and associated tissues [22] or whether it is acquired from systemic sources
[19, 20, 23, 24]. On the basis of its function as a barrier between various compartments, including the CSF, blood,
and CNS, we proposed that the CPx could play a significant role in the bidirectional dissemination of HIV between the periphery and the CNS.
We previously identified infected cells in situ and isolated HIV-1 sequences from CPx tissues [12, 25], but it
was unknown whether the CPx contains productively
infected cells. In the current study, we investigated the
genotypic and phenotypic properties of primary HIV-1
isolates derived from the spleen, CPx, and brain tissues.
Successful viral isolation was low compared with the
PCR detection of DNA sequences, possibly as a result
of long postmortem intervals, low numbers of productively infected cells in the autopsy tissues, and the isolation protocols employed.
Investigation of the env and pol genes of HIV-1 in tissues
from AIDS patients showed that there was clear compartmentalization of sequences in the brain compared
with the periphery, but this was dependent on disease
progression and the effectiveness of HAART. Although
the dataset is limited to tissues from five individuals,
these findings clearly demonstrate that the HIV-1 population contained within the CPx includes, predictably,
viruses from peripheral origin, and in addition, viruses
from the CNS. Specific analyses of viral sequences found
in the CPx tissue showed that, overall, they are more genetically like those in the brain, but still harbor sequences
similar to those in the periphery. These data are consistent with our previous study of formalin-fixed CPx tissues from four HIVE cases [12], and imply that the CPx is
a tissue in which viruses or virus-infected cells from both
peripheral and CNS sources can colocalize. This may be
pertinent to neuropathogenesis because it is likely both
to facilitate access of cytopathic or neuropathogenic
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variants to the CNS late in disease and to reseed archival strains from the CNS into the periphery, such as that
seen in studies of patients undergoing strategic therapy
interruptions of HAART who had a recurrence of drugsensitive viruses [26–29].
The pol gene, an inherently functionally conserved gene,
is targeted by most antiretroviral therapies. There is
strong evolutionary pressure on pol to retain function
and to overcome inhibition by antiretroviral drugs, resulting in the emergence of replication-competent drugresistant viral strains. In this study of late-stage AIDS
patients, there was no evidence of tissue compartmentalization of drug-resistance amino acid mutations in any
of the cases studied; however, synonymous DNA polymorphisms were tissue-specific. In particular, our study
shows that HIV-1 pol found in the CPx does evolve independently, despite being genetically similar to a specific
tissue compartment. Disease progression is likely to influence compartmentalization, and in severe immunodeficiency, as seen in case E, there is limited compartmentalization. Regardless of this, as highlighted by specific
mutations, the CPx seems to harbor viruses with resistance mutations similar to those found in other tissues.
Tissue compartmentalization of viral sequences occurs
early, and the progenitor virus is thought to evolve independently within the unique selective microenvironment [30, 31]. In the current study, the env gene of virus variants found in the CPx consisted of two genotypic
lineages, indicating that there may be a cellular restriction of HIV-1 in the CPx, presumably monocytes and T
cells. Our analyses of pol and env genes suggest that each
gene is affected independently. As a part of the innate
immunity of the CNS, the CPx possesses many cell types
that can be infected by HIV-1, and thus can provide an
environment for the transfer of neurocytopathic isolates
to monocytes and macrophages that traffic between the
CPx stroma and CSF [32, 33]. Analysis of the phenotypic
properties of HIV-1 isolated from the CPx revealed that
all were non-syncytium inducing, macrophage tropic,
and primarily utilized the CCR5 co-receptor for entry.
Furthermore, in the two viral isolates from HIVE cases,
there also existed CXCR4-tropic isolates and sequences
in the CPx. As neurons and astrocytes are more vulnerable to injury and death when exposed to CXCR4-tropic
than CCR5-tropic envelopes in vitro, the presence of
CXCR4 strains in the CPx could contribute to brain injury [34, 35]. In addition, genotype results support the
co-localization of macrophage tropic and X4 cytopathic
isolates in the CPx, because some CPx env sequences in
the CPx were similar to spleen sequences, and possessed
a higher net V3 charge than brain sequences. This property has been associated with CXCR4 usage, T-tropism,
and syncytium-inducing phenotypes [36]. Although we
have previously identified HIV-1-infected monocytes
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within the CPx stroma of AIDS patients [25], future studies will be needed to identify the specific CPx cell types
and viral genotypes able to infect them. Nevertheless, it
is clear that the colocalization of diverse viral genotypes
and phenotypes occurs within the CPx.
The blood–CSF barrier is often overlooked in HIV-1 infection, despite its probable role in entry into the CNS.
This study demonstrates that the CPx is a tissue compartment that contains replication-competent virus and may
evolve distinct viral genotypes and phenotypes, particularly neurotoxic and drug-resistant viruses. Future investigation of the interplay between HIV-1 found in the
brain, CSF, and CPx, and its relation to HAD and HIVE
will clarify the significance of the CPx in AIDS neuropathogenesis.
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